The Company acquired 740 equity shares in Labops Global Private Limited representing 74% voting power, thereby making it a subsidiary. The detailed information attached herewith
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.8 pts more than Nifty Microcap 250 and 3.6 pts more than its Consulting Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Qualitek Labs Ltd has acquired 740 equity shares in Labops Global Private Limited (formerly Protomation Technologies Pvt. Ltd.), giving it 74% voting power and making Labops a subsidiary of the company. The acquisition was completed on 23rd May, 2025, for a total cash consideration of just ₹7,400 (₹10 face value per share). Labops Global operates in laboratory setup solutions, equipment supply, lab manpower outsourcing, consultancy for accreditations, and IT/LIMS solutions — broadly aligned with Qualitek's lab operations business. The company is relatively new (incorporated April 2023) and reported nil turnover in FY 2024-25, indicating it is an early-stage entity. The board noted this acquisition is not a related party transaction and was done on an arm's length basis.
The deal is financially tiny (₹7,400 consideration) and the target has no revenue yet, so immediate earnings impact is negligible. Strategically, it sets up a subsidiary structure to build out lab operations and consultancy services, which could become meaningful over time if Labops starts generating business.